ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE
ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE
Authorised
- Danofloxacin mesilate
Product identification
Medicine name:
ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE
Advocin 180, 180 mg/ml Solution injectable pour bovins
Active substance:
- Danofloxacin mesilate
Target species:
-
Cattle
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Danofloxacin mesilate228.40milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
- Cattle
-
Meat and offal8day
-
Milk4day
-
-
Subcutaneous use
- Cattle
-
Meat and offal8day
-
Milk4day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Box containing one 100 ml vial
- Box containing one 250 ml vial
- Box containing one 50 ml vial
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V/087/02/03/0714
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0126/001
Concerned member states:
-
Belgium
-
Germany
-
Italy
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 6/03/2023
How useful was this page?: